MAHWAH, N.J. and SUNRISE, Fla., Aug. 17, 2011 /PRNewswire/ —
Stryker Corporation’s Orthopaedics Division and OrthoSensor, Inc.,
the leader in intelligent orthopaedics, today announced an
agreement in which OrthoSensor will provide the OrthoSensor™
Knee Trial, designed for use with Stryker’s Triathlon Knee System.
The OrthoSensor Knee Trial is an intelligent trial that provides
quantitative, intra-operative feedback to surgeons to optimize
joint balance during total knee arthroplasty.
The OrthoSensor Knee Trial has embedded micro-electronics and
sensors in single-use trial inserts, delivering data to optimize
the final ligament balance and patients’ specific joint kinematics.
The sensor wirelessly transmits this key information to a
graphic display of real-time feedback, enabling the surgeon to
visualize and quantify joint loading and balance. With this
evidence, the surgeon can make an informed choice to modify implant
positioning, adjust leg alignment and optimize soft tissue balance
through a full range of motion.
“The single radius design philosophy of Stryker knees is a
perfect complement to OrthoSensor’s innovative technology,” said
Doug Leach, vice president of global research and development, knee
reconstruction at Stryker Orthopaedics. “The Triathlon Knee System
is uniquely suited to the finer elements of ligament balancing and
being able to take advantage of this new offering provides us with
the opportunity to combine our advanced orthopaedic implant
technology with cutting-edge sensor technology.”
Stryker’s Triathlon Knee System offers patients the potential
for improved motion(1) and better fit(2), and remains classified as
the knee system that outperforms the most frequently used brands in
terms of revision rates as identified in the National Joint
Registry of England and Wales.(3,4).
“By integrating sensors into the surgical suite, OrthoSensor is
leading the evolution in intelligent orthopaedic
‘/>”/>
